From the Journals

Don’t use cannabis to treat OSA, AASM recommends


 

FROM THE JOURNAL OF CLINICAL SLEEP MEDICINE


“Synthetic medical cannabis may have differential side effects, with variable efficacy and side effects in the treatment of OSA. Therefore, it is the position of the American Academy of Sleep Medicine that medical cannabis and/or its synthetic extracts should not be used for the treatment of OSA,” Dr. Ramar and his associates wrote.

SOURCE: J Clin Sleep Med. 2018 April;14[4]:679-81.

Pages

Recommended Reading

Poor sleep, suicide risk linked in college students
MDedge Psychiatry
Sleep disturbance not linked to age or IQ in early ASD
MDedge Psychiatry
Insomnia, major depressive episode linked in U.S. soldiers
MDedge Psychiatry
Excessive daytime sleepiness linked to increase in Alzheimer’s biomarker
MDedge Psychiatry
MDedge Daily News: Why the barber’s chair can help hypertension
MDedge Psychiatry
Impact of sleep loss on metabolism is highly individualistic
MDedge Psychiatry
Effectiveness, adherence similar for nasal pillows and standard masks
MDedge Psychiatry
Different OSA subtypes respond differently to therapy
MDedge Psychiatry
Caffeine for apnea of prematurity found safe, effective at 11 years
MDedge Psychiatry
Disrupted sleep tied to alexithymia
MDedge Psychiatry